EARNINGS PER SHARE

3 Months Ended

12 Months Ended

Mar. 31, 2014

Dec. 31, 2013

EARNINGS PER SHARE

9. EARNINGS PER SHARE

The following table represents a reconciliation of basic and diluted earnings per share:

	March 31, 2014			December 31, 2013
Net loss used in the computation of basic and diluted earnings per share	$	(85,102,314	)	$	(20,706,448	)
Weighted average shares outstanding—basic		63,595,532			42,871,414
Common stock equivalents		—			—
Total weighted average shares outstanding—diluted		63,595,532			42,871,414
Per Share Data:
Basic
Net earnings	$	(1.36	)	$	(0.48	)
Diluted
Net earnings	$	(1.36	)	$	(0.48	)

For the periods where the Company reported losses, all common stock equivalents are excluded from the computation of diluted earnings per share, since the result would be antidilutive. Securities, that were not included in the calculation of diluted earnings per share because to do so would have been antidilutive for the periods presented, are as follows:

	March 31, 2014		December 31, 2013
Stock options		6,737,375		7,269,656
Warrants		12,140,133		775,430
Convertible debt		5,475,000		1,700,000
Total antidilutive common stock equivalents excluded from dilutive earnings per share		24,352,508		9,745,086

9. EARNINGS PER SHARE

The following table represents a reconciliation of basic and diluted earnings per share:

	2013			2012
Net loss used in the computation of basic and diluted earnings per share	$	(20,706,448	)	$	(478,170	)
Weighted average shares outstanding — basic		42,871,414			32,500,000
Common stock equivalents		—			—
Total weighted average shares outstanding — diluted		42,871,414			32,500,000
Per Share Data:
Basic
Net earnings	$	(0.48	)	$	(0.01	)
Diluted
Net earnings	$	(0.48	)	$	(0.01	)

For the periods where the Company reported losses, all common stock equivalents are excluded from the computation of diluted earnings per share, since the result would be antidilutive. Securities, that were not included in the calculation of diluted earnings per share because to do so would have been antidilutive for the periods presented, are as follows:

	Years Ended December 31
	2013		2012
Stock options		7,269,656		—
Warrants		775,430		—
Convertible debt		1,700,000		—
Total antidilutive common stock equivalents excluded from dilutive earnings per share		9,745,086		—